- JP-listed companies
- TAIKO PHARMACEUTICAL CO., LTD.
- Balance sheet
TAIKO PHARMACEUTICAL CO., LTD.【JP:4574】Balance sheet
Market cap
¥14.6B
P/E ratio
25x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | 6,119 | 2,997 | 6,803 | 6,548 | 7,225 | 9,906 | 4,945 | 5,796 | 3,105 | 5,484 | 4,532 |
| Marketable securities, current | - | - | - | - | - | - | - | - | 302 | 400 | - | - |
| Accounts receivable, net | - | 1,863 | 2,196 | 1,821 | 3,385 | 3,646 | 4,419 | 7,919 | 4,056 | 1,798 | 1,985 | 2,428 |
| Inventories | - | 1,328 | 888 | 694 | 834 | 879 | 1,346 | 5,409 | 2,010 | 696 | 421 | 452 |
| Total current assets | - | 10,478 | 7,433 | 10,276 | 11,764 | 12,572 | 16,584 | 19,822 | 13,783 | 7,556 | 9,109 | 8,761 |
| Property, plant and equipment, net | - | 7,628 | 8,410 | 8,076 | 7,895 | 7,371 | 7,108 | 9,447 | 7,113 | 6,397 | 3,581 | 3,271 |
| Marketable securities, non-current | - | - | - | 21 | 332 | 741 | 735 | 1,231 | 1,011 | 533 | 236 | 461 |
| Total non-current assets | - | 8,121 | 8,875 | 8,513 | 8,709 | 9,028 | 8,890 | 11,936 | 8,751 | 7,489 | 4,111 | 4,152 |
| Total assets | - | 18,599 | 16,307 | 18,789 | 20,473 | 21,600 | 25,474 | 31,758 | 22,535 | 15,046 | 13,220 | 12,914 |
| Accounts payable | - | 350 | 239 | 302 | 424 | 514 | 1,006 | 2,929 | 309 | 274 | 375 | 338 |
| Long-term debt, current | - | - | - | - | - | - | - | - | 923 | 1,039 | 1,206 | 1,206 |
| Total current liabilities | - | 5,004 | 2,008 | 2,237 | 2,816 | 2,826 | 4,794 | 7,488 | 4,320 | 2,793 | 3,046 | 2,855 |
| Long-term debt, non-current | - | - | - | - | - | - | - | - | 3,760 | 2,720 | 1,999 | 792 |
| Total non-current liabilities | - | 1,122 | 1,160 | 1,167 | 1,237 | 1,288 | 1,305 | 1,489 | 5,407 | 4,208 | 3,433 | 2,094 |
| Total liabilities | - | 6,126 | 3,168 | 3,404 | 4,053 | 4,115 | 6,100 | 8,976 | 9,728 | 7,001 | 6,480 | 4,949 |
| Common stock and paid-in capital | - | 639 | 818 | 1,369 | 1,573 | 1,759 | 2,271 | 2,664 | 2,849 | 2,843 | 4,956 | 5,007 |
| Retained earnings | - | 12,476 | 12,996 | 13,850 | 14,663 | 15,579 | 17,533 | 20,509 | 10,134 | 5,239 | 1,628 | 2,526 |
| Stockholders' equity | 11,406 | 12,473 | 13,140 | 15,385 | 16,420 | 17,485 | 19,374 | 22,781 | 12,807 | 8,044 | 6,739 | 7,964 |